Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.
about
Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of Clostridium diffi ...... of disease in a murine model.
@ast
Treatment of Clostridium diffi ...... of disease in a murine model.
@en
type
label
Treatment of Clostridium diffi ...... of disease in a murine model.
@ast
Treatment of Clostridium diffi ...... of disease in a murine model.
@en
prefLabel
Treatment of Clostridium diffi ...... of disease in a murine model.
@ast
Treatment of Clostridium diffi ...... of disease in a murine model.
@en
P2093
P2860
P50
P356
P1476
Treatment of Clostridium diffi ...... of disease in a murine model.
@en
P2093
Andrew J Phipps
Boris Nikonenko
Edward van Opstal
Elena Bogatcheva
Jae Hyun Shin
John H Moore
Marina Protopopova
P2860
P304
P356
10.1093/JAC/DKV479
P407
P577
2016-01-31T00:00:00Z